DESVENLAFAXINE MEDIS desvenlafaxine 100mg modified release tablets blister

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

desvenlafaxine, Quantity: 100 mg

Commercializzato da:

Medis Pharma Pty Ltd

INN (Nome Internazionale):

Desvenlafaxine

Forma farmaceutica:

Tablet, modified release

Composizione:

Excipient Ingredients: magnesium stearate; hypromellose; alginic acid; citric acid monohydrate; povidone; purified talc; microcrystalline cellulose; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black

Via di somministrazione:

Oral

Confezione:

28, 7, 14

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

For the treatment of major depressive disorder, including the preventiton of relapse. Not indicated for paediatric use.

Dettagli prodotto:

Visual Identification: Dark brown to red colored, diamond shaped, biconvex tablets, debossed with 'Ll90' on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2014-11-26